SCHEMBL31171035

SCHEMBL31171035

CSCC[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@@H](C)O

nearest known ligand 0.70

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 7/20 0.70
NPY1R P25929 1/20 0.62
NPY2R P49146 1/20 0.62
NPY4R P50391 1/20 0.62
NPY5R Q15761 1/20 0.62
GLP1R P43220 5/20 0.61
GCGR P47871 3/20 0.61
KEAP1 Q14145 1/20 0.61
MC4R P32245 1/20 0.59
MC5R P33032 1/20 0.59
MC3R P41968 1/20 0.59
MC1R Q01726 1/20 0.59
IL23R Q5VWK5 1/20 0.59
PTH1R Q03431 1/20 0.59
CTSL P07711 1/20 0.58
CTSH P09668 1/20 0.58
CTSS P25774 1/20 0.58
CTSK P43235 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29394617 0.99 CXCR4 (0.71) CXCR4NPY1RNPY2RNPY4RNPY5R
SCHEMBL31182666 0.93 CXCR4 (0.68) CXCR4NPY1RNPY2RNPY4RNPY5R
SCHEMBL30495596 0.92 CXCR4 (0.68) CXCR4NPY1RNPY2RNPY4RNPY5R
SCHEMBL31232412 0.91 NPY1R (0.68) CXCR4NPY1RNPY2RNPY4RNPY5R
SCHEMBL30658352 0.90 CXCR4 (0.71) CXCR4NPY1RNPY2RNPY4RNPY5R
SCHEMBL31067646 0.90 NPY1R (0.68) CXCR4NPY1RNPY2RNPY4RNPY5R
SCHEMBL31000406 0.90 CXCR4 (0.70) CXCR4NPY1RNPY2RNPY4RNPY5R
SCHEMBL31000409 0.89 CXCR4 (0.71) CXCR4NPY1RNPY2RNPY4RNPY5R
SCHEMBL30658320 0.89 NPY1R (0.68) CXCR4NPY1RNPY2RNPY4RNPY5R
SCHEMBL31694508 0.89 CXCR4 (0.66) CXCR4NPY1RNPY2RNPY4RNPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12290551-B2 Methods for imaging and treatment of somatostatin-receptor positive tumors CORCEPT THERAPEUTICS INCORPORATED (US) 2025-05-06 US disclosed
US-20240307504-A1 INTRANASAL FORMULATIONS AND DELIVERY OF SOMATOSTATIN MIMETICS AND USES THEREOF NBO PHARMA LLC (US) 2024-09-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12290551-B2 Methods for imaging and treatment of somatostatin-receptor positive tumors SSTR3, SSTR1, SSTR4 CXCR4 1131/4885NPY1R 24/4885NPY2R 21/4885
US-20240307504-A1 INTRANASAL FORMULATIONS AND DELIVERY OF SOMATOSTATIN MIMETICS AND USES THEREOF SSTR3, CRH, NPR3 CXCR4 1482/4885NPY1R 12/4885NPY2R 18/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.